Pure Global

The efficacy and safety of Tirzepatide for type 2 diabetes subjects with chronic kidney disease: prospective observational study - Trial UMIN000051344

Access comprehensive clinical trial information for UMIN000051344 through Pure Global AI's free database. This phase not specified trial is sponsored by Kushiro Red Cross Hospital and is currently Enrolling by invitation. The study focuses on Type 2 diabetes.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
UMIN000051344
Enrolling by invitation
Trial Details
University Hospital Medical Information Network โ€ข UMIN000051344
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
The efficacy and safety of Tirzepatide for type 2 diabetes subjects with chronic kidney disease: prospective observational study

Study Focus

Type 2 diabetes

Observational

Sponsor & Location

Kushiro Red Cross Hospital

Japan

Timeline & Enrollment

N/A

Jun 05, 2023

N/A

ICD-10 Classifications

Type 2 diabetes mellitus
Type 2 diabetes mellitus without complications
Type 2 diabetes mellitus with unspecified complications
Type 2 diabetes mellitus with other specified complications
Type 2 diabetes mellitus with multiple complications

Data Source

University Hospital Medical Information Network

UMIN000051344

Non-Device Trial